Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study-Reference-Cited by-同舟云学术

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study

Published:2010-03 Issue:3 Volume:116 Page:442-446
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kuo Dennis Yi-Shin,Blank Stephanie V.,Christos Paul J.,Kim Mimi,Caputo Thomas A.,Pothuri Bhavana,Hershman Dawn,Goldman Noah,Ivy Percy S.,Runowicz Carolyn D.,Muggia Franco,Goldberg Gary L.,Einstein Mark H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference21 articles.

1. Cancer statistics;Jemal;CA Cancer J. Clin.,2009

2. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer;Rose;N. Engl. J. Med.,1999

3. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix;Omura;J. Natl. Cancer Inst. Monogr.,1996

4. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study;Moore;J. Clin. Oncol.,2004

5. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study;Long;J. Clin. Oncol.,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal-based approaches to fight cervical cancer;Drug Discovery Today;2024-08

2. A significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7;Life Sciences;2022-11

3. RING finger protein 38 induces the drug resistance of cisplatin in non‐small‐cell lung cancer;Cell Biology International;2020-11-08

4. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer;Oncogene;2020-07-13

5. Cervical Cancer;The American Cancer Society's Oncology in Practice;2018-02-16